リコンビナントタンパク質＿精製したリコンビナントタンパク質 » SARS-CoV-2 & COVID-19関連製品 » SARS-CoV-2 Nucleocapsid protein
SARS-CoV-2 Nucleocapsid Protein

Immobilized SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric (Cat. No. A02039) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid protein (Cat. No. Z03488) with a serial dilution.
SARS-CoV-2 Nucleocapsid Antibody (HC2003) conjugated Biotin and Streptavidin-HRP (M00091), are used as a secondary antibody (1 μg/mL, 0.2 μg/mL).

SARS-CoV-2 Nucleocapsid Protein

Lane 1: 1μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 2: 3μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 3: 5μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 4: 5μg of SARS-CoV-2 Nucleocapsid protein, non-reducing(NR)
> 90% as analyzed by SDS-PAGE

SARS-CoV-2 Nucleocapsid protein

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.
Z03488
¥68,875.00

Ask us a question
Product Introduction
Species SARS-CoV-2
Protein Construction
N protein (Ser2-Ala419)
Accession # P0DTC9
Purity > 90% as analyzed by SDS-PAGE
Biological Activity SARS-CoV-2 Nucleocapsid protein can bind with SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric(Cat. No. A02039) in functional ELISA assay.
Expression System E. coli
Theoretical Molecular Weight 46 kDa
Formulation Supplied as a solution in PBS pH 7.4 containing 10% glycerol.
Concentration Please refer to the COA for the specific lot.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles.

Examples
  • SARS-CoV-2 Nucleocapsid Protein
    • SARS-CoV-2 Nucleocapsid Protein

    Immobilized SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric (Cat. No. A02039) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid protein (Cat. No. Z03488) with a serial dilution.
    SARS-CoV-2 Nucleocapsid Antibody (HC2003) conjugated Biotin and Streptavidin-HRP (M00091), are used as a secondary antibody (1 μg/mL, 0.2 μg/mL).

  • SARS-CoV-2 Nucleocapsid Protein
    • SARS-CoV-2 Nucleocapsid Protein

    Lane 1: 1μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 2: 3μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 3: 5μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 4: 5μg of SARS-CoV-2 Nucleocapsid protein, non-reducing(NR)
    > 90% as analyzed by SDS-PAGE


Background
Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.
Synonyms Coronavirus NP; coronavirus Nucleocapsid; coronavirus Nucleoprotein; Novel coronavirus Nucleoprotein; 2019-nCoV N protein

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.